These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2794863)

  • 41. Dying cells program their expedient disposal: serum amyloid P component upregulation in vivo and in vitro induced by photodynamic therapy of cancer.
    Merchant S; Sun J; Korbelik M
    Photochem Photobiol Sci; 2007 Dec; 6(12):1284-9. PubMed ID: 18046483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum amyloid P component forms a stable complex with human C5b6.
    Barbashov SF; Wang C; Nicholson-Weller A
    J Immunol; 1997 Apr; 158(8):3830-5. PubMed ID: 9103450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
    Rostagno A; Lashley T; Ng D; Meyerson J; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Revesz T; Ghiso J
    J Neurol Sci; 2007 Jun; 257(1-2):88-96. PubMed ID: 17374542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
    Hohenester E; Hutchinson WL; Pepys MB; Wood SP
    J Mol Biol; 1997 Jun; 269(4):570-8. PubMed ID: 9217261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities.
    Hedberg A; Fismen S; Fenton KA; Mortensen ES; Rekvig OP
    Exp Dermatol; 2010 Aug; 19(8):e265-74. PubMed ID: 20500770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein.
    Li XA; Yutani C; Shimokado K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):249-52. PubMed ID: 9514915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P; Hrycek A
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Agglutination of complement-coated erythrocytes by serum amyloid P-component.
    Hutchcraft CL; Gewurz H; Hansen B; Dyck RF; Pepys MB
    J Immunol; 1981 Mar; 126(3):1217-9. PubMed ID: 7462631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
    Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.
    Abdulahad DA; Westra J; Limburg PC; Kallenberg CG; Bijl M
    Autoimmun Rev; 2010 Aug; 9(10):661-5. PubMed ID: 20546955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.
    Hutchinson WL; Noble GE; Hawkins PN; Pepys MB
    J Clin Invest; 1994 Oct; 94(4):1390-6. PubMed ID: 7929814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lupus erythematosus and amyloid--amyloid deposits in skin lesions of lupus erythematosus].
    Oashi M; Kato Y
    Nihon Hifuka Gakkai Zasshi; 1972 Aug; 82(8):541-3. PubMed ID: 4539191
    [No Abstract]   [Full Text] [Related]  

  • 55. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
    Sahin S; Adrovic A; Barut K; Durmus S; Gelisgen R; Uzun H; Kasapcopur O
    Lupus; 2017 Sep; 26(10):1089-1094. PubMed ID: 28420068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue c-myc protein expression and immune response in systemic lupus erythematosus.
    Husby G; Williams RC; Watt RA; West SG; Tung KS
    Clin Exp Immunol; 1987 Sep; 69(3):493-500. PubMed ID: 3311495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The penetrating potential of autoantibodies into live cells in vitro coincides with the in vivo staining of epidermal nuclei.
    Golan TD; Sigal D; Sabo E; Shemuel Z; Guedj D; Weinberger A
    Lupus; 1997; 6(1):18-26. PubMed ID: 9116714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgG deposits can be detected in cell nuclei of patients with both lupus erythematosus and malignancy.
    Böhm I
    Clin Rheumatol; 2007 Nov; 26(11):1877-82. PubMed ID: 17364135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A cytochemical study of the L. E. bodies of systemic lupus erythematosus. II. Proteins.
    GODMAN GC; DEITCH AD
    J Exp Med; 1957 Oct; 106(4):593-606. PubMed ID: 13475616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Separation of factors in lupus erythematosus serum reacting with components of cell nuclei.
    GOODMAN HC; FAHEY JL; MALMGREN RA; BRECHER G
    Lancet; 1959 Sep; 2(7099):382-3. PubMed ID: 13851065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.